Stock Market Reviews

Read and share opinions on AURA (Aura Biosciences, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights
  Nov 13, 2025
• Owning 43% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),
  Sep 25, 2025
• Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
  Sep 3, 2025
• Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights
  Aug 13, 2025
• Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants
  May 15, 2025
• Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants
  May 15, 2025
• Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights
  May 15, 2025
• Aura Biosciences to Participate in Upcoming Investor Conferences
  May 1, 2025
• Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential?
  Apr 6, 2025
• Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors
  Apr 2, 2025
• Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
  Mar 24, 2025
• Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress
  Mar 24, 2025
• With 48% stake, Aura Biosciences, Inc. (NASDAQ:AURA) seems to have captured institutional investors' interest
  Mar 24, 2025
• Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress
  Mar 3, 2025
• Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference
  Nov 26, 2024